Quantity: 50mg

10 in stock

SKU: 1225005 Category:


Product name: Pasireotide

Catalog#: 1225005

Synonyms: Growth hormone release-inhibiting factor,

CAS NO.: 108736-35-2

Sequence: Cyclo(Hyp(2-aminoethyl-carbamoyl)-Phg-D-Trp-Lys-Tyr(Bzl)-Phe)

Modifications: disulfide(2-7)

M.W: 1096.33

M.F.: C54H69N11O10S2

Purity: 95%

Counter ion: Acetate

Format: Lyophilized powder

Description: The multireceptor-targeted SRL pasireotide (Signifor®) was initially approved in 2012 by the US Food and Drug Administration (FDA) for use in patients who were considered uncontrolled after surgical treatment of a corticotroph pituitary adenoma (Cushing’s disease). Somatotroph pituitary adenomas predominantly express somatostatin receptor (SSTR) types 2 and 5. The efficacy of pasireotide in reducing GH and IGF-1 levels and in shrinking tumor in patients with acromegaly has been evaluated in Phase III clinical trials.


Usage: For Scientific Research Use Only, Not for Human Use.



There are no reviews yet.

Be the first to review “Pasireotide”

Your email address will not be published. Required fields are marked *